Navigation Links
Endo Pharmaceuticals Reports Strong Fourth Quarter and Full-Year 2009 Financial Results: Provides 2010 Financial Guidance
Date:2/22/2010

ments within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, the company's financial position, results of operations, market position, product development and business strategy, as well as estimates of future net sales, future expenses, future net income and future earnings per share.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements.  Because these statements reflect our current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could affect our future financial results and could cause our actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to: the possibility that the acquisition of Indevus is not complementary to Endo; the inherent uncertainty of the timing and success of, and expense associated with, research, development, regulatory approval and commercialization of our products and pipeline products; competition in our industry, including for branded and generic products, and in connection with our acquisition of rights to assets, including intellectual property; government regulation of the pharmaceutical industry; our dependence on a small number of products and on outside manufacturers for the manufacture of our products; our dependence on third parties to supply raw materials and to provide services for certain core aspects of our business; new regulatory action or lawsuits relating to our use of controlled substances in many of our core products; our exposure to product liability claims and product recalls and the possibility that we may not be able to adequately insure ourselves; our ability to protect our proprietary technology; o
'/>"/>
SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Publicis Groupe ... Hartley , Managing Partner and Healthcare Industry Group Leader, ... 100, which recognizes the most inspiring people in the ... leaders in research and development, marketing, technology, creativity, strategy ... in 2006 as a partner in its leading Rosetta ...
(Date:8/21/2014)... 2014 /PRNewswire-iReach/ -- Inc. magazine today ... third straight year, No. 349 in Health on ... of the nation,s fastest-growing private companies. The list ... important segment of the economy—America,s independent entrepreneurs. Companies ... LinkedIn, Zillow, and many other well-known names gained ...
(Date:8/21/2014)... Aug. 21, 2014  Zacks.com announces the list of stocks ... Research analysts discuss the latest news and events impacting stocks ... include the Hewlett-Packard (NYSE: HPQ - Free Report ), IBM ... (NYSE: SB - Free Report ), GlaxoSmithKline plc (NYSE: ... (NYSE: FI - Free Report ). Today, ...
Breaking Medicine Technology:Shannon Hartley Shines in PharmaVOICE 100 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 2Carolina's HME Named for Third Straight Year to Inc. Magazine's List of America's Fastest-Growing Private Companies--the Inc. 5000 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 2The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 3The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 4The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 5The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 6The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 7The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 8The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 9The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 10The Zacks Analyst Blog Highlights: Hewlett-Packard, IBM, Safe Bulkers, GlaxoSmithKline and Frank's International 11
... 2, 2010 A newly released patient registry ... metal heads which articulate against polyethylene lined cups ... to implants made from any other material five ... polyethylene (XLPE), the materials in VERILAST Technology from ...
... 2010 Curemark, LLC , ( www.curemark.com ), ... treatment of neurological diseases, announced that four additional sites ... clinical trials for the company,s autism treatment CM-AT ... Institute for Behavioral Medicine, Smyrna, Georgia Cyn3rgy Research, ...
Cached Medicine Technology:New Report Indicates VERILAST™ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials 2New Report Indicates VERILAST™ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials 3New Report Indicates VERILAST™ Technology From Smith & Nephew Orthopaedics has Lowest Revision Rate Among all Hip Replacement Materials 4Curemark Announces Four New Sites Participating in Autism Study 2
(Date:8/22/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- The air ... U.S. Environmental Protection Agency reported Thursday. Significant progress ... in urban air in recent decades, the agency said ... been a nearly 60 percent reduction in mercury from ... decline in benzene, and an 84 percent fall in ...
(Date:8/22/2014)... with very low levels of nicotine may reduce ... to a new study from the University of ... journal Cancer Epidemiology monitored the smoking ... three types of cigarettes with markedly reduced nicotine ... cigarette brandsall of which have very similar levels ...
(Date:8/22/2014)... August 22, 2014 Goats are taking over ... Foods, attends the 10th annual Pre-Emmy Awards Boom Boom Room. ... try the best new products for kids on August 23 ... p.m., and we’ll be encouraging them to #GoGoat for L.A. ... excited to present our gentle, non-GMO goat milk foods to ...
(Date:8/22/2014)... For the fourth time, TharpeRobbins, a global leader ... received a prestigious level of recognition from Inc. Magazine. ... remains on the exclusive list of top 5000 fastest ... the list in 2010, 2011 and 2013. , ... list for a fourth time," says Brett Tharpe, CEO ...
(Date:8/22/2014)... Hills, CA (PRWEB) August 22, 2014 The ... that has become known as the premier event for ... Body Boot Camp founder, fitness marketing expert and Spike TV ... has always been strictly for Fit Body franchise owners. This ... known for sharing some really great information from some really ...
Breaking Medicine News(10 mins):Health News:Air in U.S. Cities Getting Cleaner, EPA Says 2Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:#GoGoat with Kabrita at the Pre-Emmy Awards Boom Boom Room 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 2Health News:For The Fourth Time - TharpeRobbins Earns A Place On Prestigious Inc. Magazine 500|5000 List 3Health News:Fit Body Boot Camp World Conference 2014 Set To Maintain Reputation as Fitness Boot Camp Marketing Event of the Year 2Health News:Fit Body Boot Camp World Conference 2014 Set To Maintain Reputation as Fitness Boot Camp Marketing Event of the Year 3
... Consuming Vitamin B ,With the rising costs of healthcare, ... a cheap and effective way of warding off health ... and heart disease//. ,Research in the past ... acid known to be a marker of cardiovascular disease ...
... bald mice to get fur on the body, says a ... C. Thompson and colleagues at Johns Hopkins University School// of ... encodes a protein that is essential for hair follicle regeneration. ... Hairless gene, hair growth is initially normal. But once hair ...
... Sometimes the answers to complex problems lies at hand but ... case with a new anti obesity drug//. A weight control ... monitor body fat content may yield new approaches for treating ... further suggest that particular variants of the protein SH2-B might ...
... is considering whether to temporarily ban the Environmental Protection ... a pesticide should be marketed//. Lawmakers on Capitol Hill ... moratorium on the conduct and use of studies that ... conducted by companies seeking to have their pesticides approved ...
... Manipur have hope at hand with an international aid ... care and treatment//.,The Nobel prize-winning Medicines Sans Frontieres (MSF) ... understanding with the Manipur government to provide healthcare services, ... Dutch chapter of the MSF would be involved in ...
... some people vulnerable to suffer from the dreaded disease ... diagnose the risk//. ,According to the most complete ... the researchers from Vanderbilt University in Nashville, Tennessee at ... in San Diego, a cluster of genes on chromosome ...
Cached Medicine News:Health News:An Answer To Obesity: Weight Control Protein 2Health News:US Senate Votes against Testing of Pesticide on Humans 2Health News:Specialized Clinics For Manipur's AIDS Patients 2
The Olympus continuous flow cystoscope was especially designed for laser treatment of the prostate and for collagen injection....
... Prostatron® System uses Cooled ... -TUMT®) to deliver precisely ... heat and destroy hyperplastic ... unique cooling mechanism simultaneously ...
... provides diagnostic testing in an easily ... a PCMCIA card,providing you diagnostic testing ... full-featured and performs all the,measurements performed ... to Office,Medic software for real-time data ...
... is a simple "1, 2, 3 ... compact with a streamline design It ... 13.5 lbs. It rapidly charges to ... full summary pre- & post-event documentation ...
Medicine Products: